Bio-Rad Laboratories

+$32.38 (+4.58%) Today

$0.00 (0.00%) As of 10:58 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIO and other ETFs, options, and stocks.

About BIO

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments.

CEO

Norman D. Schwartz

Employees

8,000

Headquarters

Hercules, California

Founded

1952

BIO Key Statistics

Market Cap

22.07B

Price-Earnings Ratio

5.20

Dividend Yield

—

Average Volume

108.06K

High Today

$756.52

Low Today

$714.00

Open Price

$714.00

Volume

289.51K

52 Week High

$756.52

52 Week Low

$472.84

BIO News

BenzingaJul 29

Recap: Bio-Rad Laboratories Q2 Earnings

Shares of Bio-Rad Laboratories (NYSE:BIO) moved higher by 0.2% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per s

ReutersJul 27

Bio-Rad, 10x Genomics settle genomics patent war

REUTERS/Lim Huey Teng Summary Summary Related documents Settlement ends long-running, multi-front dispute over genetic-analysis tech Parties agree to cross-l

Analyst Ratings

83%

of 6 ratings

Buy

83.3%

Hold

Sell

16.7%

BIO Earnings

$1.15

$2.50

$3.86

$5.21

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

$2.66 per share

Actual

$3.54 per share

Replay Earnings Call